Abstract
For a long time the endothelium was considered as a passive exchange barrier of lipoproteins between plasma and extravascular tissues. During the past two decades many data from clinical studies, cell culture, and animal experiments have shown that endothelial cells are a target of physiological and pathological actions of lipoproteins: Whereas lysosphingolipids and apolipoprotein (apo)A-I in native high-density lipoproteins (HDL) exert protective effects on the integrity and function of endothelial cells, modified low-density lipoproteins (LDL) and remnants of lipoproteins tend to disturb endothelial function. One central function of the endothelium is the control of protein trafficking between intravascular and extravascular compartments. Both LDL and HDL can pass the intact endothelium through transcytosis by processes which involve caveolin-1 and the LDL-receptor (for LDL) or ATP-binding cassette (ABC) transporters and scavenger receptor (SR)-BI for apoA-I and HDL, respectively. Finally the endothelium has evolved as a regulator of lipoprotein metabolism: By expressing or presenting lipases [lipoprotein lipase (LPL), hepatic lipase (HL), endothelial lipase (EL)] as well as LPL-receptors (glycerophosphatidyl inositol anchored HDL binding protein 1; GPIHBP1) the endothelium contributes to the remodelling of all lipoprotein classes. Selective conditional knock-outs of widely expressed genes like peroxisome proliferator agent receptor gamma (PPARγ) in mice are starting to reveal additional specific effects of the endothelium on lipid and lipoprotein metabolism.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ansell BJ, Fonarow GC, Fogelman AM (2007) The paradox of dysfunctional high-density lipoprotein. Curr Opin Lipidol 18:427– 434
Argraves KM, Argraves WS (2007) HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects. J Lipid Res 48:2325–2333
Argraves KM, Gazzolo PJ, Groh EM, Wilkerson BA, Matsuura BS, Twal WO, Hammad SM, Argraves WS (2008) High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function. J. Biol Chem 283:25074–25081
Badellino KO, Rader DJ (2004) The role of endothelial lipase in high-density lipoprotein metabolism. Curr Opin Cardiol 19:392–395
Badellino KO, Wolfe ML, Reilly MP, Rader DJ (2006) Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis. PLoS Med 3:e22
Bai H, Liu BW, Deng ZY, Shen T, Fang DZ, Zhao YH, Liu Y (2006) Plasma very-low-density lipoprotein, low-density lipoprotein, and high-density lipoprotein oxidative modification induces procoagulant profiles in endogenous hypertriglyceridemia. Free Radic Biol Med 40:1796–1803
Baker PW, Rye KA, Gamble JR, Vadas MA, Barter PJ (2000) Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression. J Lipid Res 41:1261–1267
Balazs Z, Panzenboeck U, Hammer A, Sovic A, Quehenberger O, Malle E, Sattler W (2004) Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood-brain barrier model. J Neurochem 89:939–950
Barrans A, Collet X, Barbaras R, Jaspard B, Manent J, Vieu C, Chap H, Perret B (1994) Hepatic lipase induces the formation of pre-beta 1 high density lipoprotein (HDL) from triacylglycerol-rich HDL2. A study comparing liver perfusion to in vitro incubation with lipases. J Biol Chem 269:11572–11577
Beigneux AP, Davies BS, Gin P, Weinstein MM, Farber E, Qiao X, Peale F, Bunting S, Walzem RL, Wong JS, Blaner WS, Ding ZM, Melford K, Wongsiriroj N, Shu X, de Sauvage F, Ryan RO, Fong LG, Bensadoun A, Young SG (2007) Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab 5:279–291
Beigneux AP, Davies BS, Bensadoun A, Fong LG, Young SG (2008) GPIHBP1 – a GPI-anchored protein required for the lipolytic processing of triglyceride-rich lipoproteins. J Lipid Res (in press)
Bishop JR, Stanford KI, Esko JD (2008) Heparan sulfate proteoglycans and triglyceride-rich lipoprotein metabolism. Curr Opin Lipidol 19:307–313
Bisoendial RJ, Hovingh GK, Levels JH, Lerch PG, Andresen I, Hayden MR, Kastelein JJ, Stroes ES (2003) Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein. Circulation 107:2944–2948
Born GV, Medina R, Shafi S, Cardona-Sanclemente LE (2003) Factors influencing the uptake of atherogenic plasma proteins by artery walls. Biorheology 40:13–22
Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J, Kiowski W, Lüscher TF, Mancia G, Natali A, Oliver JJ, Pessina AC, Rizzoni D, Rossi GP, Salvetti A, Spieker LE, Taddei S, Webb DJ (2005) Working group on endothelins and endothelial factors of the european society of hypertension. Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the working group on endothelins and endothelial factors of the european society of hypertension. J Hypertens 23:233–246
Cavelier C, Rohrer L, von Eckardstein A (2006) ATP-binding cassette transporter A1 modulates apolipoprotein A-I transcytosis through aortic endothelial cells. Circ Res 99:1060–1066
Chao WT, Fan SS, Chen JK, Yang VC (2003) Visualizing caveolin-1 and HDL in cholesterol-loaded aortic endothelial cells. J Lipid Res 44:1094–1099
Davignon J, Ganz P (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 109[Suppl 1]:III27–32
Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation 115:1285–1295
Dehouck B, Fenart L, Dehouck MP, Pierce A, Torpier G, Cecchelli R (1997) A new function for the LDL receptor: transcytosis of LDL across the blood–brain barrier. J Cell Biol 138:877–889
Dunn S, Vohra RS, Murphy JE, Homer-Vanniasinkam S, Walker JH, Ponnambalam S (2008) The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochem J 409:349–355
Evans M, Berhane Y, Botham KM, Elliott J, Wheeler-Jones CP (2004) Chylomicron-remnant-like particles modify production of vasoactive mediators by endothelial cells. Biochem Soc Trans 32:110–112
Félétou M, Vanhoutte PM (2007) Endothelium-dependent hyperpolarizations: past beliefs and present facts. Ann Med 39:495–516
Feng Y, Jacobs F, Van Craeyveld E, Brunaud C, Snoeys J, Tjwa M, Van Linthout S, De Geest B (2008a) Human ApoA-I transfer attenuates transplant arteriosclerosis via enhanced incorporation of bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol 28:278–283
Feng Y, van Eck M, Van Craeyveld E, Jacobs F, Carlier V, Van Linthout S, Erdel M, Tjwa M, De Geest B (2009) Critical role of scavenger receptor-BI expressing bone marrow-derived endothelial progenitor cells in the attenuation of allograft vasculopathy after human apo A-I transfer. Blood 113:755–764
Forte TM, Shu X, Ryan RO (2008) The ins (cell) and outs (plasma) of apolipoprotein A-V. J Lipid Res (in press)
Frank PG, Lee H, Park DS, Tandon NN, Scherer PE, Lisanti MP (2004) Genetic ablation of caveolin-1 confers protection against atherosclerosis. Arterioscler Thromb Vasc Biol 24:98–105
Frank PG, Pavlides S, Cheung MW, Daumer K, Lisanti MP (2008) Role of caveolin-1 in the regulation of lipoprotein metabolism. Am J Physiol Cell Physiol 295:C242–C248
Frank PG, Pavlides S, Lisanti MP (2009) Caveolae and transcytosis in endothelial cells: role in atherosclerosis. Cell Tissue Res 335:41–47
Gauster M, Oskolkova OV, Innerlohinger J, Glatter O, Knipping G, Frank S (2004) Endothelial lipase-modified high-density lipoprotein exhibits diminished ability to mediate SR-BI (scavenger receptor B type I)-dependent free-cholesterol efflux. Biochem J 382:75–82
Gleissner CA, Leitinger N, Ley K (2007) Effects of native and modified low-density lipoproteins on monocyte recruitment in atherosclerosis. Hypertension 50:276–283
Goti D, Balazs Z, Panzenboeck U, Hrzenjak A, Reicher H, Wagner E, Zechner R, Malle E, Sattler W (2002) Effects of lipoprotein lipase on uptake and transcytosis of low density lipoprotein (LDL) and LDL-associated alpha-tocopherol in a porcine in vitro blood–brain barrier model. J Biol Chem 277:28537–28544
Guendouzi K, Collet X, Perret B, Chap H, Barbaras R (1998) Remnant high density lipoprotein2 particles produced by hepatic lipase display high-affinity binding and increased endocytosis into a human hepatoma cell line (HEPG2). Biochemistry 37:14974–14980
Hasham SN, Pillarisetti S (2006) Vascular lipases, inflammation and atherosclerosis. Clin Chim Acta 372:179–183
Hu G, Minshall RD (2009) Regulation of transendothelial permeability by Src kinase. Microvasc Res 77:21–25
Ishida T, Choi S, Kundu RK, et al (2003) Endothelial lipase is a major determinant of HDL level. J Clin Invest 111:347–355
Ishida T, Choi SY, Kundu RK, Spin J, Yamashita T, Hirata K, Kojima Y, Yokoyama M, Cooper AD, Quertermous T (2004) Endothelial lipase modulates susceptibility to atherosclerosis in apolipoprotein-E-deficient mice. J Biol Chem 279:45085–45092
Jaye M, Krawiec J (2004) Endothelial lipase and HDL metabolism. Curr Opin Lipidol 15:183–189
Jensen JS, Feldt-Rasmussen B, Jensen KS, Clausen P, Scharling H, Nordestgaard BG (2004) Transendothelial lipoprotein exchange and microalbuminuria. Cardiovasc Res 63:149–154
Kanda T, Brown JD, Orasanu G, Vogel S, Gonzalez FJ, Sartoretto J, Michel T, Plutzky J (2009) PPARgamma in the endothelium regulates metabolic responses to high-fat diet in mice. J Clin Invest. 119:110–124
Kawakami A, Tanaka A, Nakajima K, Shimokado K, Yoshida M (2002) Atorvastatin attenuates remnant lipoprotein-induced monocyte adhesion to vascular endothelium under flow conditions. Circ Res 91:263–271
Kimura T, Sato K, Kuwabara A, Tomura H, Ishiwara M, Kobayashi I, Ui M, Okajima F (2001) Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells. J Biol Chem 276:31780–31785
Kimura T, Sato K, Malchinkhuu E, Tomura H, Tamama K, Kuwabara A, Murakami M, Okajima F (2003) High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors. Arterioscler Thromb Vasc Biol 23:1283–1288
Kimura T, Tomura H, Mogi C, Kuwabara A, Damirin A, Ishizuka T, Sekiguchi A, Ishiwara M, Im DS, Sato K, Murakami M, Okajima F (2006) Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells. J Biol Chem 281:37457–37467
Ko KW, Paul A, Ma K, Li L, Chan L (2005) Endothelial lipase modulates HDL but has no effect on atherosclerosis development in apoE–/– and LDLR–/– mice. J Lipid Res 46:2586–2594
Komarova YA, Mehta D, Malik AB (2007) Dual regulation of endothelial junctional permeability. Sci STKE 2007:re8
Kornerup K, Nordestgaard BG, Feldt-Rasmussen B, Borch-Johnsen K, Jensen KS, Jensen JS (2003) Increased transvascular low density lipoprotein transport in insulin dependent diabetes: a mechanistic model for development of atherosclerosis. Atherosclerosis 170:163–168
Kornerup K, Nordestgaard BG, Jensen TK, Feldt-Rasmussen B, Eiberg JP, Jensen KS, Jensen JS (2004) Transendothelial exchange of low-density lipoprotein is unaffected by the presence of severe atherosclerosis. Cardiovasc Res 64:337–345
Kratzer I, Wernig K, Panzenboeck U, Bernhart E, Reicher H, Wronski R, Windisch M, Hammer A, Malle E, Zimmer A, Sattler W (2007) Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood–brain barrier. J Control Release 117:301–311
Lamarche B, Paradis ME (2007) Endothelial lipase and the metabolic syndrome. Curr Opin Lipidol 18:298–303
Li D, Mehta JL (2000) Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vasc Biol 20:1116–1122
Mehta D, Malik AB (2006) Signaling mechanisms regulating endothelial permeability. Physiol Rev 86:279–367
Mineo C, Shaul PW (2007) Role of high-density lipoprotein and scavenger receptor B type I in the promotion of endothelial repair. Trends Cardiovasc Med 17:156–161
Mineo C, Yuhanna IS, Quon MJ, Shaul PW (2003) High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases. J Biol Chem 278:9142–9149
Mineo C, Deguchi H, Griffin JH, Shaul PW (2006) Endothelial and antithrombotic actions of HDL. Circ Res 98:1352–1364
Miura S, Fujino M, Matsuo Y, Kawamura A, Tanigawa H, Nishikawa H, Saku K (2003a) High density lipoprotein-induced angiogenesis requires the activation of Ras/MAP kinase in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 23:802–808
Miura S, Tanigawa H, Matsuo Y, Fujino M, Kawamura A, Saku K (2003b) Ras/Raf1-dependent signal in sphingosine-1-phosphate-induced tube formation in human coronary artery endothelial cells. Biochem Biophys Res Commun 306:924–929
Nofer JR, Assmann G (2005) Atheroprotective effects of high-density lipoprotein-associated lysosphingolipids. Trends Cardiovasc Med 15:265–271
Nofer JR, Fobker M, Höbbel G, Voss R, Wolinska I, Tepel M, Zidek W, Junker R, Seedorf U, von Eckardstein A, Assmann G, Walter M (2000) Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid. Involvement in mitogenesis but not in cholesterol efflux. Biochemistry 39:15199–15207
Nofer JR, Levkau B, Wolinska I, Junker R, Fobker M, von Eckardstein A, Seedorf U, Assmann G (2001) Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J Biol Chem 276:34480–34485
Nofer JR, Geigenmüller S, Göpfert C, Assmann G, Buddecke E, Schmidt A (2003) High density lipoprotein-associated lysosphingolipids reduce E-selectin expression in human endothelial cells. Biochem Biophys Res Commun 310:98–103
Nofer JR, van der Giet M, Tölle M, Wolinska I, von Wnuck Lipinski K, Baba HA,Tietge UJ, Gödecke A, Ishii I, Kleuser B, Schäfers M, Fobker M, Zidek W, Assmann G, Chun J, Levkau B (2004) HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest 113:569–581
Noor R, Shuaib U, Wang CX, Todd K, Ghani U, Schwindt B, Shuaib A (2007) High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing eNOS and preventing apoptosis. Atherosclerosis 192:92–99
Norata GD, Catapano AL (2005) Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium. Vasc Health Risk Manag 1:119–129
Norata GD, Pirillo A, Callegari E, Hamsten A, Catapano AL, Eriksson P (2003) Gene expression and intracellular pathways involved in endothelial dysfunction induced by VLDL and oxidised VLDL. Cardiovasc Res 59:169–180
Norata GD, Callegari E, Inoue H, Catapano AL (2004) HDL3 induces cyclooxygenase-2 expression and prostacyclin release in human endothelial cells via a p38 MAPK/CRE-dependent pathway: effects on COX-2/PGI-synthase coupling. Arterioscler Thromb Vasc Biol 24:871–877
Nordestgaard BG, Wootton R, Lewis B (1995) Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media. Arterioscler Thromb Vasc Biol 15:534–542
Obunike JC, Lutz EP, Li Z, Paka L, Katopodis T, Strickland DK, Kozarsky KF, Pillarisetti S, Goldberg IJ (2001) Transcytosis of lipoprotein lipase across cultured endothelial cells requires both heparan sulfate proteoglycans and the very low density lipoprotein receptor. J Biol Chem 276:8934–8941
Oravec S, Demuth K, Myara I, Hornych A (1998) The effect of high density lipoprotein subfractions on endothelial eicosanoid secretion. Thromb Res 92:65–71
Pan W, Kastin AJ, Zankel TC, van Kerkhof P, Terasaki T, Bu G (2004) Efficient transfer of receptor-associated protein (RAP) across the blood–brain barrier. J Cell Sci 117:5071–5078
Pantano C, Reynaert NL, van der Vliet A, Janssen-Heininger YM (2006) Redox-sensitive kinases of the nuclear factor-kappaB signaling pathway. Antioxid Redox Signal 8:1791–1806
Paradis ME, Badellino KO, Rader DJ, et al (2006) Visceral adiposity and endothelial lipase. J Clin Endocrinol Metab 91:3538–3543
Perret B, Mabile L, Martinez L, Tercé F, Barbaras R, Collet X (2002) Hepatic lipase: structure/function relationship, synthesis, and regulation. J Lipid Res 43:1163–1169
Petoumenos V, Nickenig G, Werner N (2008) High density lipoprotein exerts vasculoprotection via endothelial progenitor cells. J Cell Mol Med (in press)
Plotnick GD, Corretti MC, Vogel RA (1997) Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. JAMA 278:1682–1686
Pollin TI, Damcott CM, Shen H, Ott SH, Shelton J, Horenstein RB, Post W, McLenithan JC, Bielak LF, Peyser PA, Mitchell BD, Miller M, O’Connell JR, Shuldiner AR (2008) A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science 322:1702–1705
Qiu G, Hill JS (2009) Endothelial lipase promotes apolipoprotein AI-mediated cholesterol efflux in THP-1 macrophages. Arterioscler Thromb Vasc Biol 29:84–91
Ren S, Shen GX (2000) Impact of antioxidants and HDL on glycated LDL-induced generation of fibrinolytic regulators from vascular endothelial cells. Arterioscler Thromb Vasc Biol 20:1688–1693
Rippe B, Rosengren BI, Carlsson O, Venturoli D (2002) Transendothelial transport: the vesicle controversy. J Vasc Res 39:375–390
Robbesyn F, Garcia V, Auge N, Vieira O, Frisach MF, Salvayre R, Negre-Salvayre A (2003) HDL counterbalance the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-kappaB activation in smooth muscle cells. FASEB J 17:743–745
Rohrer L, Cavelier C, Fuchs S, Schlüter MA, Völker W, von Eckardstein A (2006) Binding, internalization and transport of apolipoprotein A-I by vascular endothelial cells. Biochim Biophys Acta 1761:186–194
Rohrer L, Zemp M, Lorenzi I, Lehnert M, von Eckardstein A (2007) HDL transport through endothelial cells is mediated by ABCG1 and SR-BI. Arterioscler Thromb Vasc Biol 27:e36
Rosenfeld SI, Packman CH, Leddy JP (1983) Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins. J Clin Invest 71:795–808
Rosenson RS, Lowe GD (1998) Effects of lipids and lipoproteins on thrombosis and rheology. Atherosclerosis 140:271–280
Rye KA, Barter PJ (2004) Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I. Arterioscler Thromb Vasc Biol 24:421–428
Schwenke DC, Carew TE (1989) Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs selective increases in LDL permeability in susceptible sites of arteries. Arteriosclerosis 9:908–18
Seetharam D, Mineo C, Gormley AK, Gibson LL, Vongpatanasin W, Chambliss KL, Hahner LD, Cummings ML, Kitchens RL, Marcel YL, Rader DJ, Shaul PW (2006) High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ Res 98:63–72
Shin HK, Kim YK, Kim KY, Lee JH, Hong KW (2004) Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol. Circulation 109:1022–1028
Simionescu M (2007) Implications of early structural–functional changes in the endothelium for vascular disease. Arterioscler Thromb Vasc Biol 27:266–274
Speidel MT, Booyse FM, Abrams A, Moore MA, Chung BH (1990) Lipolyzed hypertriglyceridemic serum and triglyceride-rich lipoprotein cause lipid accumulation in and are cytotoxic to cultured human endothelial cells High density lipoproteins inhibit this cytotoxicity. Thromb Res 58:251–264
Spencer BJ, Verma IM (2007) Targeted delivery of proteins across the blood–brain barrier. Proc Natl Acad Sci USA 104:7594–7599
Spieker LE, Sudano I, Hürlimann D, Lerch PG, Lang MG, Binggeli C, Corti R, Ruschitzka F, Lüscher TF, Noll G (2002) High-density lipoprotein restores endothelial function in hypercholesterolemic men. Circulation 105:1399–1402
Suc I, Escargueil-Blanc I, Troly M, Salvayre R, Nègre-Salvayre A (1997) HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL. Arterioscler Thromb Vasc Biol 17:2158–2166
Sugano M, Tsuchida K, Makino N (2000) High-density lipoproteins protect endothelial cells from tumor necrosis factor-alpha-induced apoptosis. Biochem Biophys Res Commun 272:872–876
Sumi M, Sata M, Miura S, Rye KA, Toya N, Kanaoka Y, Yanaga K, Ohki T, Saku K, Nagai R (2007) Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol 27:813–818
Tabas I, Williams KJ, Borén J (2007) Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 116:1832–1844
Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T (1997) Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 95:76–82
Tso C, Martinic G, Fan WH, Rogers C, Rye KA, Barter PJ (2006) High-density lipoproteins enhance progenitor-mediated endothelium repair in mice. Arterioscler Thromb Vasc Biol 26:1144–1149
van den Berg BM, Spaan JA, Vink H (2009). Impaired glycocalyx barrier properties contribute to enhanced intimal low-density lipoprotein accumulation at the carotid artery bifurcation in mice. Pflugers Arch 457:1199–1206
van Gils JM, Zwaginga JJ, Hordijk PL (2009). Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leukoc Biol 85:195–204
van Oostrom O, Nieuwdorp M, Westerweel PE, Hoefer IE, Basser R, Stroes ES, Verhaar MC (2007) Reconstituted HDL increases circulating endothelial progenitor cells in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol 27:1864–1865
Viswambharan H, Ming XF, Zhu S, Hubsch A, Lerch P, Vergères G, Rusconi S, Yang Z (2004) Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase. Circ Res 94:918–925
von Otte S, Paletta JR, Becker S, König S, Fobker M, Greb RR, Kiesel L, Assmann G, Diedrich K, Nofer JR (2006) Follicular fluid high density lipoprotein-associated sphingosine 1-phosphate is a novel mediator of ovarian angiogenesis. J Biol Chem 281:5398–5405
Weinstein MM, Yin L, Beigneux AP, Davies BS, Gin P, Estrada K, Melford K, Bishop JR, Esko JD, Dallinga-Thie GM, Fong LG, Bensadoun A, Young SG (2008) Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice. J Biol Chem 283:34511–34518
Wheeler-Jones CP (2007) Chylomicron remnants: mediators of endothelial dysfunction? Biochem Soc Trans 35:442–445
Wong H, Schotz MC (2002) The lipase gene family. J Lipid Res 43:993–999
Xia P, Vadas MA, Rye KA, Barter PJ, Gamble JR (1999) High density lipoproteins (HDL) interrupt the sphingosine kinase signalling pathway. A possible mechanism for protection against atherosclerosis by HDL. J Biol Chem 274:33143–33147
Yatomi Y (2008) Plasma sphingosine 1-phosphate metabolism and analysis. Biochim Biophys Acta 1780:606–611
Yuhanna IS, Zhu Y, Cox BE, Hahner LD, Osborne-Lawrence S, Lu P, Marcel YL, Anderson RG, Mendelsohn ME, Hobbs HH, Shaul PW (2001) High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat Med 7:853–857
Zambon A, Bertocco S, Vitturi N, Polentarutti V, Vianello D, Crepaldi G (2003) Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins. Biochem Soc Trans 31:1070–1074
Zampetaki A, Kirton JP, Xu Q (2008) Vascular repair by endothelial progenitor cells. Cardiovasc Res 78:413–421
Zhang Q, Liu L, Zheng XY (2008) Protective roles of HDL, apoA-I and mimetic peptide on endothelial function: through endothelial cells and endothelial progenitor cells. Int J Cardiol (in press)
Zhao R, Ma X, Shen GX (2008) Transcriptional regulation of plasminogen activator inhibitor-1 in vascular endothelial cells induced by oxidized very low density lipoproteins. Mol Cell Biochem 317:197–204
Zheng XY, Liu L (2007) Remnant-like lipoprotein particles impair endothelial function: direct and indirect effects on nitric oxide synthase. J Lipid Res 48:1673–1680
Zhu W, Saddar S, Seetharam D, Chambliss KL, Longoria C, Silver DL, Yuhanna IS, Shaul PW, Mineo C (2008) The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity. Circ Res 102:480–487
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
von Eckardstein, A., Rohrer, L. (2009). Role of the Endothelium in Lipoprotein Metabolism. In: Ehnholm, C. (eds) Cellular Lipid Metabolism. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-00300-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-00300-4_7
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-00299-1
Online ISBN: 978-3-642-00300-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)